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ABSTRACT
Differentiation of bone marrow (BM)-derived cells into lung epithelial cells has been reported in vivo
in animal models of lung injury. Most studies have used cytokeratin or surfactant protein expression
as markers of BM-to-lung cell differentiation. However, concerns as to whether fusion rather than dif-
ferentiation is the mechanism involved, verification of BM-derived lung cells, and inconsistent findings
with different injury models mean that the differentiation potential of BM-derived cells remains un-
clear. We used a co-culture system, in which BM cell–lung cell fusion is prevented, to examine the abil-
ity of ‘damage’ signals released from mechanically disrupted lung tissue to induce expression of lung-
related genes in BM-derived cells in vitro. BM-derived hematopoietic progenitor cells (BM-HPCs) were
co-cultured with mechanically disrupted lung tissue. Liver tissue and medium-only co-cultures were
also studied as controls. BM-HPCs differentiated into myeloid cells in culture. BM-HPCs proliferated
in response to soluble lung damage signals and differentiated into suspension and adherent populations
with dendritic cell- and Langerhans cell-like characteristics, respectively. Induction or up-regulation of
cytokeratins 7 and 18 and surfactant protein B mRNA expression occurred in the suspension, dendritic
cell (DC)-like population during co-culture with lung tissue. In contrast, these genes were not induced
or up-regulated in medium-only or liver co-cultures. Up-regulation of E-cadherin mRNA and protein
expression also occurred in response to lung damage signals. These results confirm that signals released
from damaged lung tissue can induce lung-related gene expression in BM-derived DC-like cells in the
absence of cell fusion.
1
INTRODUCTION
IT HAS BEEN REPORTED that bone marrow (BM)-derivedcells can engraft in various tissues in vivo, including
lung, heart, liver, kidney, and skin, and differentiate into
host tissue-type cells (reviewed in ref. 1). Most lung stud-
ies have involved delivery of donor BM-derived cells to
recipient mice that have some form of lung injury. Sub-
sequent apparent co-expression of donor markers, such
as the Y chromosome or green fluorescent protein (GFP),
with lung epithelial cell markers, usually cytokeratins and
surfactant proteins, has been reported and proposed to
imply differentiation of BM cells into lung epithelial cells
(2–14). However, issues such as identification of BM-de-
rived epithelial cells, the types of BM-derived cells in-
volved, differentiation versus fusion, and relevance of the
mode of lung injury have yet to be clarified. As a result,
BM cell involvement in reconstitution of the lung ep-
ithelium in vivo remains controversial.
In 2001, Krause et al. reported that a single BM-derived
donor hematopoietic stem cell (HSC) could give rise to
bronchial and type II cells in lethally irradiated recipient
mice, as determined by co-localization of the Y chromo-
some with cytokeratin protein and surfactant protein B
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(SP-B) mRNA (2). In the same year, Kotton et al. dem-
onstrated that plastic-adherent BM cells could engraft in
lungs of bleomycin-injured mice (3). Expression of the
type I cell protein T1 in BM-derived cells and binding
of the type I cell-specific lectin Lycopersicon esculentum
was reported. No engraftment as type II cells was detected.
Krause and co-workers subsequently used whole BM that
was either male donor-derived (10) or contained a GFP re-
porter gene (4) to demonstrate BM cell differentiation into
type I and type II cells in lethally irradiated mice, again
using cytokeratin protein and SP-B mRNA as lung mark-
ers. Other studies reported that BM side population (SP)
cells give rise to alveolar (5) and tracheal cells (6) that ex-
press cytokeratin proteins in injured, but not in healthy,
mice that Flk1/CD31/CD34 cells from human fetal
BM can contribute to lung epithelial regeneration in irra-
diated nonobese diabetic/severe combined immunodefi-
cient (NOD/SCID) mice (7) and that BM-derived mes-
enchymal stem cells (MSCs) can give rise to type II cells
(8) and also type I cells and lung fibroblasts during
bleomycin-induced lung injury (13).
Other reports have refuted some of these findings
however. In contrast to Krause et al. (2), Wagers and co-
workers reported that single GFP-labeled HSCs did not
contribute appreciably to nonhematopoietic tissues, in-
cluding lung, in lethally irradiated recipients (14). Debate
also centers on the techniques used to identify putative
BM-derived lung cell phenotypes in situ. Studies using
deconvolution microscopy and lineage-specific reporter
systems to identify BM-derived SP-C-expressing lung
cells reported overlapping or tightly juxtaposed cells that
could have appeared as false-positive donor-derived ep-
ithelial cells by conventional microscopy (15,16). Prob-
lems may also be associated with GFP reporter systems.
It has been suggested that the low level of GFP expres-
sion detectable in donor-derived lung cells in vivo may
be due to fusion and subsequent donor gene inactivation
(6). However, GFP expression levels can vary in the tis-
sues of different strains of GFP donor mice, with some
strains containing only approximately 40% GFP-positive
mononuclear cells in the marrow (17). Furthermore, in
one strain of reporter mice that use the -actin promoter
to drive GFP expression, offspring usually die a few
months after birth, indicating that unknown detrimental
effects of GFP expression exist that may affect studies
using cells derived from these animals (17). Robust
demonstration of efficacy of reporter systems such as
GFP is therefore essential.
It has been proposed that the mode and extent of tis-
sue injury influences the extent to which BM-derived
cells engraft and contribute to regeneration (17). Pre-
sumably, signals from damaged lung tissue enhance hom-
ing and engraftment of donor BM cells to the lungs and
their differentiation into lung epithelial cells (18). As well
as depleting BM cells in recipient animals, irradiation
causes lung damage. Recently, it has been shown that
BM-to-lung cell differentiation only occurs if irradiation
levels are above the threshold that induces lung damage
(19). However, inconsistent findings between animal
studies involving irradiation have been reported (2,14).
Although differentiation of BM cells into lung epithelial
cells is predicted to result in co-expression of donor mark-
ers with lung epithelial cell markers, fusion of BM cells to
host cells could result in the same phenotype. Fusion has
been shown to take place in the liver, brain, and heart in
vivo (20–22). It is not clear if fusion or differentiation or
both occur in the lung. Krause and co-workers found no
evidence of fusion in an in vivo model using whole BM
(23) whereas Spees et al. observed both differentiation and
fusion in vitro using BM-derived MSCs (24). A subsequent
study by this group, however, using a different co-culture
system, found no evidence of fusion of MSCs with lung
epithelial cells (12). Neither is it clear whether donor cells
that engraft in the lungs arrive directly following injection,
which is unlikely in the case of a single-donor HSC, or are
recruited via the bone marrow. In the latter case, the cell
type that ultimately engrafts in the lung may not be the
same as the original donor population. It will be essential
to determine which, if any, BM-derived cells are capable
of expressing lung-related genes if they are to be used for
gene delivery or targeted repair.
In this study, we tested the hypothesis that soluble lung
‘damage’ signals, such as those released from disrupted
lung cells and extracellular matrices, can induce lung-re-
lated gene expression in BM-derived cells in the absence
of fusion. An in vitro co-culture system was used in which
BM cells were physically separated from mechanically
macerated lung tissue obtained from otherwise healthy
animals. Induction of cytokeratin and surfactant genes,
as reported from in vivo studies, was determined. The co-
culture system addressed three key issues associated with
the in vivo studies. First, only soluble lung-derived sig-
nals could interact with the BM cells and potential BM
cell/lung cell fusion was prevented. Second, the BM-de-
rived cells could be characterized before and after co-cul-
ture to identify the cell types involved. And third, be-
cause only BM-derived cells were harvested for analysis,
doubts regarding the true identity of cells expressing
lung-related genes were eliminated. Using this system,
we have demonstrated induction of lung-related gene ex-
pression in BM-derived DC-like cells in vitro in response
to soluble signals released from damaged lung tissue.
MATERIALS AND METHODS
BM cell isolation and lineage depletion
BM cells were isolated from 6- to 8-week-old female
C3H-Hen mice (Harlen, UK). Care of animals was in ac-
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cordance with institutional guidelines. Following cervi-
cal dislocation, whole bone marrow was obtained by
flushing the femurs and tibias with an ice-cold solution
of phosphate-buffered saline (PBS) with 0.5% bovine
serum albumin (BSA), and 2 mM EDTA. Red blood cells
were lysed using an RBC Lysis Solution (Biolegend, San
Diego, CA). A population enriched for hematopoietic
progenitor cells was obtained from the remaining cell sus-
pension using a negative-selection cell isolation system
according to manufacturer’s instructions (R&D Systems,
Abingdon, UK). Briefly, cells were labeled with a cock-
tail of biotinylated antibodies against a panel of hemato-
poietic lineage marker antigens (CD5, CD45R, CD11b,
Gr-1, 7-4, and Ter-119) and then incubated with anti-bi-
otin magnetic beads. The magnetically labeled lineage-
positive cells were separated by retention in a 6-ml tube
within a magnetic field, whereas the unlabeled cells were
eluted. Magnetic separation was carried out three times.
Unlabeled cells were finally eluted and retained for cul-
ture or characterization. These cells are referred to as
BM-derived hematopoietic progenitor cells (BM-HPCs).
Co-culture system
BM culture medium comprised of RPMI-1640 (Sigma,
Tallaght, Ireland), 10% conditioned medium from Giant
Cell Tumour (Sigma), 13.5% heat-inactivated fetal
bovine serum (FBS; Gibco, Poole, UK), 2 mM L-Glut
(Gibco), and 50 mg/L gentamicin sulfate (Sigma). Lung
and liver tissues used in co-culture experiments were har-
vested from the same animals used to obtain BM cells
or, in GFP co-culture experiments, from GFP-expressing
FVB.Cg-Tg (GFPU) 5Nagy/J mice (Jackson Labora-
tories). Four grams wet weight of each tissue was
chopped into approximately 1-mm2 cubes and mixed with
6 ml of BM culture medium. Next, 800 l of the result-
ing suspension was placed in a well of a 24-well tissue
culture plate. A total of 1.5  105 HPCs in 330 l of BM
culture medium were seeded into tissue culture inserts
that had a 0.4-m membrane pore size. Inserts were
placed into wells containing the disaggregated tissue sus-
pension or control medium. Plates were incubated at
37°C, 5% CO2 for up to 3 days. Cells were harvested at
day 2 and day 3. Suspension cells were analyzed sepa-
rately from the adherent population.
Dendritic cell isolation and co-culture
BM cells were obtained by flushing the leg bones of
6- to 8-week-old female C3H-Hen mice, as above. Den-
dritic cells (DCs) were cultured as previously described
(25) with minor modifications. Nonadherent immature
DCs were harvested at day 7 and either analyzed by flow
cytometry or co-cultured as follows: 5  105 DCs in ei-
ther 1 ml of BM culture medium or 1 ml of DC medium
(21) were seeded into six-well tissue culture plate inserts.
Inserts were placed into six-well plates containing 2 ml
of control medium, lung tissue, or liver tissue per well.
Adherent and suspension cells were harvested at day 3
of co-culture for subsequent RT-PCR analysis.
Cell counts
Suspension cell numbers were determined using an
ethidium bromide/acridine orange staining solution and
viewing with a UV microscope. Adherent cells were
counted using a DAPI nuclear stain and a fluorescent mi-
croscope. A two-tailed t-test was used to determine sig-
nifcance.
Characterization of cells by flow cytometry
The extent of progenitor cell enrichment in the BM-
HPC population was determined by flow cytometry. Lin-
eage-depleted cells, already labeled with biotinylated lin-
eage marker antibodies during the separation procedure,
were resuspended in PBS with 1% BSA and incubated
with phycoerythrin (PE)-conjugated or PE-Cy7-conju-
gated anti-mouse-CD117, fluorescein isothiocyanate
(FITC)-conjugated anti-mouse CD34, biotinylated anti-
mouse CD45, FITC-conjugated anti-mouse Sca1, and
FITC-conjugated anti-mouse CD90 (eBiosciences, San
Diego, CA). Cells were also relabeled with biotinylated
lineage marker antibodies to ensure adequate labeling
during separation. Biotinylated antibodies were detected
with subsequent addition of Streptavidin-APC (eBio-
sciences). At day 3 of culture, suspension cells harvested
from the co-culture system were labeled with PE-conju-
gated anti-mouse CD11b antibody, FITC-conjugated
anti-mouse CD11c, FITC-conjugated anti-mouse F4/80,
PE-conjugated MHC Class II, and biotinylated anti-
mouse Gr-1 antibody with subsequent incubation with
Streptavidin-APC (eBiosciences). Immature DCs har-
vested at day 7 were used as controls. Isotype antibody
controls (eBiosciences) were performed for all of the an-
tibodies used. Flow cytometry was performed using a
FACSCalibur instrument (Becton Dickinson, Cowley,
UK) and analyzed using CellQuest software (Becton
Dickinson).
Immunofluorescence
Adherent cells were fixed in ice-cold methanol for 
5 min. Primary antibodies used were rat anti-mouse
CD11b, rat anti-mouse CD11c, rat anti-mouse F4/80
(eBiosciences), mouse anti-mouse E-cadherin (BD
Pharmingen, San Diego, CA). Secondary antibodies used
were Alexafluor 488 and Alexafluor 568 (Molecular
Probes, Invitrogen). Immunofluorescence was detected
with a fluorescent microscope. Phase-contrast images
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were taken at 20 magnification using an Olympus dig-
ital camera, model C310.
RT-PCR
Total RNA was prepared from both suspension and ad-
herent cells harvested at day 2 and day 3 using TriReagent
(Sigma) according to the manufacturer’s instructions. Sam-
ples were treated with DNase I, Amp Grade (Invitrogen,
Paisley, UK) for 30 min and cDNA was synthesized us-
ing Moloney murine leukemia virus (M-MLV) Reverse
Transcriptase (Invitrogen). PCR primers were designed us-
ing ‘Primer 3’ Web software (Whitehead Institute for Bio-
medical Research, MA). PCR consisted of 35 cycles 94°C
for 45 sec (denaturation), 58°C (unless otherwise stated)
for 1 min (annealing), and 72°C for 2 min (extension) us-
ing a PTC-100 programmable thermal cycler (MJ Re-
search, Inc., Bio-Rad, Waltham, MA). The PCR primers
were as follows: SP-A, 5-AAG TGC AAT GGG ACA
GAA-3 and 5-AAG TTG ACT GAC TGC CCA-3,
product 389 bp; SP-B, 5-CTA CCT GCC CCT GGT
TAT-3 and 5-GAC TTG CAG AAA TGG CAC-3, prod-
uct 549 bp; SP-C, 5-GGT GAT TGT AGG GGC TCT-
3 and 5-AAG AAT CGG ACT CGG AAC-3, product
365 bp; SP-D, 5-TGC CTT CTC CCA CTA TCA-3 and
5-CAC AGA TAA CAA GGC GCT-3, 55°C annealing
temperature, product 392 bp; CC-10, 5-ATC GCC ATC
ACA ATC ACT-3, 5-GAA TCT TAA ATC TTG CTT
ACA CAG AGG-3, 55°C annealing temperature, product
282 bp; cytokeratin 7, 5-GCA GGA TGT GGT GGA
AGA TT-3 and 5-TCT GCG ATG CTG GAC TCT AA-
3, product 507 bp; cytokeratin 8, 5-CTG ACC GAC
GAG ATC AAC-3 and 5-GCT CTG CAG CTC CTC
ATA-3, product 225 bp; cytokeratin 18, 5-AGA CTG
GGG CCA CTA CTT CA-3 and 5-CTG ATT TCG GCA
GAC TTG GT-3, product 498 bp; cytokeratin 19, 5-TGA
TCG TCT CGC CTC CTA CT-3 and 5-AAT CCA CCT
CCA CAC TGA CC-3, product 452 bp; ECAD, 5-GGC
TGG ACC GAG AGA GTT-3 and 5-CTG CTT GGC
CTC AAA ATC C-3, product 350 bp; GAPDH, 5-CTG
CAC CAC CAA CTG CTT AG-3 and 5-TGA GGG
AGA TGC TCA GTG TT-3, 55°C annealing tempera-
ture, 30 PCR cycles, product 487 bp. Absence of contam-
inating genomic DNA was confirmed for each RT-PCR
experiment using controls that omitted M-MLV. GAPDH
was used as a housekeeping gene and cDNA template was
equalized to give equivalent bands of GAPDH. Mouse air-
way epithelial cells (AECs) were isolated as previously de-
scribed (26) and used as a positive control for RT-PCR.
Flow cytometry for protein expression in
suspension cells
Suspension cells were analyzed at day 3 for lung-re-
lated protein expression by flow cytometry. Cells were
harvested, washed twice in ice-cold PBS, and fixed and
permeabilized as previously described (27). Briefly, cells
were fixed in 0.25% paraformaldehyde for 1 h at 4°C,
centrifuged, and permeabilized in 0.2% Tween-20 for 15
min at 37°C. Cells were then centrifuged, incubated in
blocking serum for 20 min at room temperature and pri-
mary antibody for 30 min at 4°C. Following two wash
steps, cells were blocked again and incubated with sec-
ondary antibody. Cells were washed twice again in 0.2%
Tween-20, and once in PBS, 2% FBS, and 0.1% sodium
azide, before resuspension in PBS, 2% FBS, and 0.1%
sodium azide. Primary antibodies used were mouse anti-
mouse E-cadherin (BD Pharmingen), rabbit anti-sheep
surfactant protein-B (Chemicon, Hampshire, UK), and
mouse anti-mouse Pan-keratin (Sigma). The secondary
antibody used was Alexafluor 488 (Molecular Probes, In-
vitrogen). Flow cytometry was performed using a FAC-
SCalibur instrument (Becton Dickinson, Cowley, UK)
and analyzed using CellQuest software (Becton Dickin-
son).
RESULTS
Initial experiments using whole BM
In vivo studies using whole BM have reported differ-
entiation of BM cells into lung epithelial cells (4). There-
fore, we began by determining the effects of soluble sig-
nals from mechanically macerated lung tissue on
lung-related gene expression in whole BM cultures. Co-
cultures with medium alone or with liver tissue were used
as controls. Following co-culture, BM cells were har-
vested and examined for induction of SP-B, CC-10, cy-
tokeratin 7, cytokeratin 18, and cytokeratin 19 mRNA
expression using RT-PCR. Induction of these mRNAs
was detectable in some samples at some timepoints in re-
sponse to soluble lung-derived signals, but not in
medium-only or liver controls. However, no consistent
pattern of gene expression was determinable (results not
shown). It was hypothesized that large populations of ma-
ture, lineage-positive (lin), whole BM cells were ob-
scuring visualization of lung-related gene expression in
smaller stem cell subpopulations. Therefore, a population
of cells enriched for lineage-negative progenitor cells,
BM-HPCs, was isolated and examined in co-culture.
Characterization of BM-HPCs after 
lineage depletion
Separation of mature hematopoietic cells (T cells, B
cells, monocytes/macrophages, granulocytes and ery-
throcytes and their committed precursors) from whole
BM was carried out. First, red cell lysis reduced the num-
ber of whole BM cells by approximately one third. Sub-
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sequently, 0.93 % of the remaining cell population was
harvested following separation (n  3). On average, 91%
of this BM-HPC population was lin as determined by
relabeling with lineage antibodies. These cells were fur-
ther characterized to be 72% CD117, 59% CD34, 51%
CD45, 25% Sca1, and 9% CD90. Approximately
10% were CD117 CD45 indicating that approximately
90% of the BM-HPC population were of hematopoietic
lineage (n  2). Results of a representative experiment
are shown in Fig. 1. Data averaged from three separate
experiments are shown in Table 1.
Proliferation of BM-HPCs in co-culture
BM-HPCs were cultured in complete medium con-
taining 10% Giant Cell Tumour conditioned medium.
This was used to promote the growth of hematopoietic
cells due to its combination of colony stimulating fac-
tors—granulocyte-macrophage colony-stimulating factor
(GM-CSF), granulocyte colony-stimulating factor (G-
CSF), and macrophage colony-stimulating factor (M-
CSF), amongst other factors. Therefore, the BM-HPCs
differentiated once placed in culture, and we will refer to
cultured BM-HPCs as BM-derived myeloid cells, BM-
MCs, from this point onward.
Although most BM-MCs remained in suspension dur-
ing co-culture, approximately 24%, 17%, and 14% ad-
hered to the tissue culture inserts in medium-only, lung,
and liver co-cultures, respectively, by day 3. Suspension
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FIG. 1. Characterization of BM-HPCs. Graphs show results from
a typical experiment: (light line) isotype control, (heavy line) char-
acterizing antibody. See Table 1 for mean results from multiple ex-
periments.
F1 
T1 
TABLE 1. CHARACTERIZATION OF
FRESHLY ISOLATED BM-HPCS
Characterizing antibody Percentage cells
Lin 90.63%  6.35
CD117 71.63%  2.57
CD45 50.51%  5.03
CD34 58.75%  5.01
Sca1 24.78%  4.57
CD90 8.67%  4.17
*CD117  CD45 10.83%  2.13
Table shows mean results from three individual experiments
(*n  2).
and adherent populations were analyzed separately from
this point onward.
Suspension and adherent cells were counted separately
and a total cell count was determined. Although total cell
numbers remained relatively constant when cultured with
medium alone, co-culture with lung tissue resulted in a
4.7-fold increase in total BM-MC cell number compared
to seeding density (Fig. 2). In contrast, a decline in total
BM-MC cell number occurred during co-culture with
liver tissue.
Effects of co-culture on BM-MC phenotype
The effects of co-culture on BM-MC phenotype, with
medium-only and in the presence of soluble signals from
lung tissue, were determined. Results of a typical exper-
iment are shown in Fig. 3. Mean values from multiple
experiments are shown in Table 2. Suspension BM-MCs
were harvested for characterization by flow cytometry.
By day 3 of co-culture, BM-MCs co-cultured with
medium alone had become CD11bhi CD11c Gr-1lo
F4/80lo MHC II. In contrast, BM-MCs co-cultured with
lung tissue showed up-regulation of CD11c and were
MHC IIlo. For comparison, CD11c expression in control
immature DCs was examined. BM-MCs co-cultured with
lung were 37% CD11c whereas immature DCs were
67% CD11c. These expression profiles indicate that sol-
uble signals from lung tissue induced BM-MCs to dif-
ferentiate toward a DC-like phenotype.
Adherent BM-MCs were analyzed by immunofluores-
cence for CD11b, CD11c, F4/80, and E-cadherin ex-
pression at day 3 of co-culture (Fig. 4A). Adherent cells,
whether co-cultured with medium alone or with lung or
liver tissue, were over 97 % CD11b and negative for
CD11c. Adherent cells in medium-only co-cultures were
very weakly positive for F4/80 and did not express E-
cadherin protein. In contrast, 72% of adherent cells co-
cultured with lung tissue were strongly positive for F4/80
and expressed high levels of E-cadherin, which was lo-
calized to the cell membrane and at regions of cell-to-
cell contact. This expression pattern of is indicative of a
Langerhans-like cell type. Phase-contrast images (Fig.
4B) show a marked change in morphology from control
cells to cells co-cultured with lung tissue.
Effects of co-culture on lung-related gene
expression in BM-MCs
Lung-related gene expression was analyzed by RT-
PCR. Suspension and adherent BM-MCs were harvested
at day 3 and analyzed for expression of E-cadherin, CC-
10, surfactant protein, and cytokeratin mRNA. Total
RNA extracted from primary mouse AECs was used a
positive control.
SP-B gene expression was not detected in suspension
BM-MCs co-cultured with either control medium or liver
tissue (Fig. 5). In contrast, SP-B gene expression was in-
duced in suspension BM-MCs co-cultured with lung tissue.
Expression of SP-A, SP-C, SP-D, and CC-10 mRNA was
not detected in any BM-MC co-cultured cells (results not
shown). Low-level cytokeratin 18 mRNA expression was
evident in day-0 freshly isolated BM-MCs as expected. Al-
though BM cells do not contain cytokeratin proteins, cy-
tokeratin mRNA transcripts are present in these cells (28).
Up-regulation of cytokeratin 18 gene expression occurred
in BM-MCs co-cultured with lung tissue, but not in
medium-only or liver co-cultures. Induction of cytokeratin
7 expression occurred in BM-MCs co-cultured with lung
tissue at day 3, but not in control- or liver co-cultures. In-
duction of cytokeratin 19 was also detected only in BM-
MCs co-cultured with lung tissue, but expression was in-
consistent. There was no induction of cytokeratin 8 mRNA
(results not shown). E-cadherin mRNA expression was up-
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FIG. 2. Proliferation of BM-HPCs in co-culture. Graph rep-
resents mean of three separate experiments. Co-culture with
lung tissue resulted in a 4.6-fold increase in BM-HPC cell num-
ber. Cell numbers were significantly higher than those in
medium-only controls at day 2 and day 3 (**  p  0.01). Cells
in medium-only remained relatively constant whereas cell num-
bers declined in co-culture with damaged liver tissue. Adher-
ent cells represent approximately 24%, 17%, and 14% of con-
trol (C), lung (Lu), and liver (Liv) co-cultures by day 3.
FIG. 3. Characterization of suspension BM-MCs at day 3 of co-culture. Graphs are representative of three separate experi-
ments. (A) Characterization of BM-MCs in medium-only co-culture. Cells are CD11bhi CD11c Gr-1lo F4/80lo MHCII, in-
dicative of BM-derived myeloid cells. (B) Characterization of BM-MCs in co-culture with lung tissue. Cells are CD11bhi CD11clo
Gr-1lo F4/80lo MHCIIlo, indicating that BM-MCs are differentiating toward a DC-like phenotype. (C) Characterization of im-
mature DCs (Imm DCs) for comparison.
F3 
T2 
F4
F5
F2 

regulated in BM-MCs co-cultured with lung tissue com-
pared to medium-only co-cultures.
Adherent cells were analyzed for expression of the
same genes but only E-cadherin mRNA expression was
detected (Fig. 5). Cytokeratin 18 mRNA was detected oc-
casionally, but not consistently, in BM-MCs co-cultured
with lung tissue.
It is highly unlikely that tissue-derived RNA or cells
crossed into the inserts to give rise to false-positive RT-
PCR results in BM-MCs. First, liver cells contain cytok-
eratin 7, 18, and 19 mRNA transcripts and proteins, yet
cytokeratin expression was never detected by RT-PCR in
BM-HPCs co-cultured with damaged liver tissue. Second,
no RT-PCR bands were detected in controls experiments
where medium without BM-HPCs was co-cultured with
lung or liver tissue extracts (results not shown). In addi-
tion, co-cultures using BM-HPCs from wild-type mice and
lung tissue from FVB.Cg-Tg (GFPU) 5Nagy/J mice
ubiquitously expressing GFP were carried out. No GFP
mRNA was detected in harvested BM-MCs cells and no
GFP-positive adherent cells were present on the tissue cul-
ture insert when viewed by microscopy (n  2, results not
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TABLE 2. CHARACTERIZATION OF SUSPENSION
BM-MCS AT DAY 3 OF CO-CULTURE
Day-3 control Day-3 Lu Imm DCs
CD11b 89.7%  2.9 91.8%  2.5 95.27%  0.8
CD11c 6.1%  4.5 36.9%  3.0 67.17%  2.3
Gr-1 19.6%  12.6 17.0%  8.3 9.13%  3.6
F4/80 18.7%  13.2 13.3%  3.3 47.48%  9.4
MHC II 0.8%  1.3 9.5%  4.5 34.57%  8.2
Table shows mean results from three individual experiments
using medium-only and lung tissue co-cultures. Immature DCs
(Imm DCs) were used as a comparison (n  2).
AU1 
FIG. 4. (A) Characterization of adherent BM-MCs at day 3 of co-culture. Photomicrographs are representative of three sepa-
rate experiments. DAPI is used as a nuclear counterstain. BM-MCs in medium-only co-culture (Ctrl) are CD11b CD11c F4/80lo
ECAD. BM-MCs in co-culture with lung tissue are CD11bCD11c F4/80 ECAD, indicating a Langerhans cell-like phe-
notype. Secondary antibody controls, omitting primary antibodies, demonstrate lack of nonspecific binding. (B) Phase-contrast
images taken at 20 magnification show a marked change in morphology.
shown). Furthermore, immunofluorescence for E-cadherin
was carried out using a green fluorescent secondary anti-
body to confirm that cells expressing E-cadherin were not
GFP-positive and therefore were not derived from lung tis-
sue below the insert (results not shown).
Induction of lung-related protein expression
Because SP-B, cytokeratin and E-cadherin mRNA ex-
pression was induced or up-regulated in suspension BM-
MCs co-cultured with lung tissue, expression of corre-
sponding proteins was examined by flow cytometry. No
SP-B or cytokeratin protein was detected in suspension
BM-MCs co-cultured with either medium alone or with
lung tissue. Expression of E-cadherin protein was in-
duced in approximately 11% of BM-MCs co-cultured
with lung tissue compared to 2.8% of BM-MCs co-cul-
tured with medium only (Fig. 6). Although E-cadherin is
not lung-specific and is expressed by DCs, it is involved
in integration into epithelium and therefore may play a
role in BM-derived cell engraftment during regeneration.
Co-culture using immature DCs
Co-culture of BM-HPCs with lung tissue produced a
DC-like phenotype capable of co-expressing lung-related
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FIG. 5. RT-PCR analysis of suspension cells and adherent BM-MCs at day 2 and day 3 of co-culture. W, no cDNA control;
AEC, airway epithelial cell; 0, day zero freshly isolated BM-HPCs; C, BM-MCs co-cultured in medium-only; Lu, BM-MCs co-
cultured with lung tissue; Liv, BM-MCs co-cultured with liver tissue; ECAD, E-cadherin; SP-B, surfactant protein B; K7, cy-
tokeratin 7; K18, cytokeratin 18; K19, cytokeration 19 (*inconsistent result). SP-B, K7, and K19* were induced in co-culture
with lung tissue whereas K18 and E-cadherin were up-regulated.
FIG. 6. E-cadherin protein expression in BM-MCs co-cul-
tured with lung tissue at day 3. Graph is representative of three
separate experiments. (Light line) isotype control, (heavy line)
E-cadherin antibody. Approximately 11% of cells co-cultured
with lung tissue expressed E-cadherin compared with 2.8% of
BM-MCs in medium only controls.
F6 
genes. Therefore, we examined whether soluble signals
from lung tissue could induce lung-related gene expres-
sion in immature DCs derived in vitro from cultured BM.
No induction of lung-related genes was detected in co-
cultured DCs grown in either BM culture medium or DC
culture medium (results not shown).
DISCUSSION
In vivo studies indicate that BM-derived cells can con-
tribute to regeneration of injured lung epithelia. How-
ever, a number of concerns relating to these studies mean
that the phenomenon of BM-to-lung epithelial cell dif-
ferentiation remains controversial. We endeavored to ver-
ify in vivo findings of lung-related gene expression in
BM-derived cells by using an in vitro system that elim-
inated many of the confounding factors associated with
animal studies. The co-culture system prevented BM
cell–lung cell fusion and facilitated retrieval of BM-de-
rived cells for characterization and analysis of lung-re-
lated gene expression. Using this system, we have con-
firmed that soluble ‘damage’ signals from mechanically
disrupted lung tissue can induce or up-regulate expres-
sion of several of those genes used as markers of BM-
to-lung epithelial cell differentiation in vivo, namely cy-
tokeratins and surfactant protein B.
The co-culture system enabled us closely to examine
separate BM-derived subpopulations as they emerged in
culture in response to soluble lung damage signals. The
BM-HPCs used here proliferated in response to these sol-
uble lung damage signals and differentiated into suspen-
sion and adherent populations with DC- and Langerhans
cell-like characteristics, respectively. Interestingly, under
current conditions, lung-related gene expression occurred
only in the BM-MC suspension, DC-like population.
However, when in vitro-derived immature DCs were co-
cultured with lung tissue, no lung-related gene expres-
sion was detected. This may indicate that a more imma-
ture myeloid precursor population, capable of expressing
cytokeratin and surfactant protein B, was present in the
BM-MC population, but not in the in vitro-derived DC
population.
Expression of cytokeratin and surfactant proteins did not
occur in BM-MCs. This may reflect differences in soluble
and nonsoluble factors present in vitro and in vivo, such
as cell–cell contact with epithelial cells, for example. Al-
ternatively, the cells used in this study may not be capa-
ble of ultimately expressing lung-related proteins. It is pos-
sible however that the time points looked at in these
experiments did not allow for protein synthesis.
It is interesting to note that DCs are recruited to the
lung during inflammation and integrate into the epithe-
lium via E-cadherin interactions with epithelial cells (29).
Therefore, DCs would appear to be ideal candidates for
BM-derived cell engraftment and regeneration of injured
lung epithelia. In addition, type II pneumonocytes have
certain features in common with DCs. They express ma-
jor histocompatibility complex II (MHC II) and are
among the few nonprofessional antigen-presenting cell
types in the body (30). Type II cells also express
CD208/dendritic cell-lysosomal associated membrane
protein (DC-LAMP), a protein originally described as
specific to DCs (31,32). Therefore, there may be a closer
relationship between type II cells and DCs than currently
understood.
In summary, we have demonstrated that BM-derived
DC-like cells are capable of expressing lung-related
genes, specifically those used as markers of BM-to-lung
cell differentiation in vivo. Induction or up-regulation of
these genes appears to occur in response to soluble sig-
nals from damaged lung tissue and in the absence of cell
fusion.
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